{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:58:23Z","timestamp":1791248303145,"version":"4.1.0"},"reference-count":24,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2020,12,1]]},"DOI":"10.1001\/jamaophthalmol.2020.3989","type":"journal-article","created":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T15:11:50Z","timestamp":1602774710000},"page":"1234","source":"Crossref","is-referenced-by-count":38,"title":["Lifetime Outcomes of Anti\u2013Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration"],"prefix":"10.1001","volume":"138","author":[{"given":"Robert P.","family":"Finger","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, University of Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Therese","family":"Puth","sequence":"additional","affiliation":[{"name":"IMBIE, Faculty of Medicine, University of Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Schmid","sequence":"additional","affiliation":[{"name":"IMBIE, Faculty of Medicine, University of Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Barthelmes","sequence":"additional","affiliation":[{"name":"Sydney Medical School, Save Sight Institute, Discipline of Ophthalmology and Eye Health, The University of Sydney, Sydney, New South Wales, Australia"},{"name":"Department of Ophthalmology, University Hospital Zurich, University of Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn H.","family":"Guymer","sequence":"additional","affiliation":[{"name":"Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, Victoria, Australia"},{"name":"Ophthalmology, Department of Surgery, The University of Melbourne, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Gillies","sequence":"additional","affiliation":[{"name":"Sydney Medical School, Save Sight Institute, Discipline of Ophthalmology and Eye Health, The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"9827","key":"eoi200076r1","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/S0140-6736(12)60282-7","article-title":"Age-related macular degeneration.","volume":"379","author":"Lim","year":"2012","journal-title":"Lancet"},{"issue":"4","key":"eoi200076r2","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1080\/09286586.2017.1281426","article-title":"The economic impact of blindness in Europe.","volume":"24","author":"Chakravarthy","year":"2017","journal-title":"Ophthalmic Epidemiol"},{"issue":"14","key":"eoi200076r3","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1056\/NEJMoa062655","article-title":"Ranibizumab versus verteporfin for neovascular age-related macular degeneration.","volume":"355","author":"Brown","year":"2006","journal-title":"N Engl J Med"},{"issue":"1","key":"eoi200076r4","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ophtha.2007.03.008","article-title":"The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis.","volume":"115","author":"Wong","year":"2008","journal-title":"Ophthalmology"},{"issue":"8","key":"eoi200076r5","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1016\/j.ophtha.2016.03.045","article-title":"Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: the comparison of age-related macular degeneration treatments trials.","volume":"123","author":"Maguire","year":"2016","journal-title":"Ophthalmology"},{"issue":"9","key":"eoi200076r6","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1016\/j.ophtha.2015.05.010","article-title":"Long-term outcomes of treatment of neovascular age-related macular degeneration: data from an observational study.","volume":"122","author":"Gillies","year":"2015","journal-title":"Ophthalmology"},{"issue":"11","key":"eoi200076r7","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1002\/sim.v29:11","article-title":"Multi-state Markov models for disease progression in the presence of informative examination times: an application to hepatitis C.","volume":"29","author":"Sweeting","year":"2010","journal-title":"Stat Med"},{"issue":"1","key":"eoi200076r8","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1097\/IAE.0b013e318296b271","article-title":"Efficient capture of high-quality data on outcomes of treatment for macular diseases: the fight retinal blindness! Project.","volume":"34","author":"Gillies","year":"2014","journal-title":"Retina"},{"issue":"12","key":"eoi200076r9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081042","article-title":"Visual impairment as a function of visual acuity in both eyes and its impact on patient reported preferences.","volume":"8","author":"Finger","year":"2013","journal-title":"PLoS One"},{"issue":"10","key":"eoi200076r10","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1136\/bjo.86.10.1118","article-title":"Vision impairment and older drivers: who\u2019s driving?","volume":"86","author":"Keeffe","year":"2002","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"eoi200076r11","doi-asserted-by":"publisher","first-page":"865","DOI":"10.5014\/ajot.49.9.865","article-title":"Basic concepts and terms for low vision rehabilitation.","volume":"49","author":"Colenbrander","year":"1995","journal-title":"Am J Occup Ther"},{"issue":"1","key":"eoi200076r12","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1159\/000098518","article-title":"Disability evolution in multiple sclerosis: how to deal with missing transition times in the Markov model?","volume":"28","author":"Petiot","year":"2007","journal-title":"Neuroepidemiology"},{"issue":"1","key":"eoi200076r13","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/(ISSN)1097-0258","article-title":"Hidden Markov models for the onset and progression of bronchiolitis obliterans syndrome in lung transplant recipients.","volume":"21","author":"Jackson","year":"2002","journal-title":"Stat Med"},{"issue":"12","key":"eoi200076r14","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.exger.2005.08.011","article-title":"Influence of level of education on disability free life expectancy by sex: the ILSA study.","volume":"40","author":"Minicuci","year":"2005","journal-title":"Exp Gerontol"},{"issue":"8","key":"eoi200076r15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v038.i08","article-title":"Multi-state models for panel data: the msm package for R.","volume":"38","author":"Jackson","year":"2011","journal-title":"J Stat Softw"},{"issue":"1","key":"eoi200076r16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.survophthal.2013.03.009","article-title":"Predictors of anti-VEGF treatment response in neovascular age-related macular degeneration.","volume":"59","author":"Finger","year":"2014","journal-title":"Surv Ophthalmol"},{"issue":"2","key":"eoi200076r17","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ajo.2011.10.016","article-title":"Incidence of legal blindness from age-related macular degeneration in denmark: year 2000 to 2010.","volume":"153","author":"Bloch","year":"2012","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"eoi200076r18","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.ajo.2011.08.035","article-title":"Time trends in the incidence and causes of blindness in Israel.","volume":"153","author":"Skaat","year":"2012","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"eoi200076r19","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1038\/eye.2015.83","article-title":"Long-term visual outcomes of intravitreal ranibizumab treatment for wet age-related macular degeneration and effect on blindness rates in south-east Scotland.","volume":"29","author":"Borooah","year":"2015","journal-title":"Eye (Lond)"},{"issue":"2","key":"eoi200076r20","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1080\/09286586.2017.1397701","article-title":"Risk factors for discontinuation of treatment for neovascular age-related macular degeneration.","volume":"25","author":"Westborg","year":"2018","journal-title":"Ophthalmic Epidemiol"},{"issue":"4","key":"eoi200076r21","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1080\/17482960701278562","article-title":"Disease progression and survival in ALS: first multi-state model approach.","volume":"8","author":"Gil","year":"2007","journal-title":"Amyotroph Lateral Scler"},{"issue":"7","key":"eoi200076r22","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1136\/bjophthalmol-2011-301201","article-title":"Patients\u2019 preferences in treatment for neovascular age-related macular degeneration in clinical routine.","volume":"96","author":"Finger","year":"2012","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"eoi200076r23","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.ophtha.2013.12.032","article-title":"The impact of anti-vascular endothelial growth factor treatment on quality of life in neovascular age-related macular degeneration.","volume":"121","author":"Finger","year":"2014","journal-title":"Ophthalmology"},{"issue":"10","key":"eoi200076r24","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1002\/sim.v38.10","article-title":"A joint model for dynamic prediction in uveitis.","volume":"38","author":"Grand","year":"2019","journal-title":"Stat Med"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2771739\/jamaophthalmology_finger_2020_oi_200076_1607382300.38863.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T16:50:41Z","timestamp":1607619041000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2771739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,1]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2020.3989","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,1]]}}}